FIELD: medicine.
SUBSTANCE: invention relates to a method of treating hidradenitis suppurativa. A proposed method of treating hidradenitis suppurativa (HS) in a subject having lesions associated with hidradenitis suppurativa comprises the step of administering to the subject in need thereof the following compound [(1S)-2,2-difluorocyclopropyl][(1R,5S)-3-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-3,8-diazabicyclo[3.2.1]oct-8-yl]methanone, which specifically inhibits Tyk2/JAK1, or its pharmaceutically acceptable salt.
EFFECT: use of the invention provides effective, safe and well-tolerated treatment for patients with moderate to severe HS.
7 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE AND ITS APPLICATIONS | 2020 |
|
RU2803145C2 |
| AMINOPYRIMIDINYL DERIVATIVES | 2021 |
|
RU2817349C1 |
| 6-(PYRIMIDINOAMINO-PYRIDINE)BENZOIMIDAZOLE DERIVATIVES, USEFUL FOR TREATMENT OF CANCER | 2014 |
|
RU2670762C2 |
| HETEROCYCLIC JANUS KINASE 3 INHIBITORS | 2006 |
|
RU2434013C2 |
| SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
| INHIBITOR OF CERTAIN PROTEIN KINASES | 2016 |
|
RU2732952C2 |
| 5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
| METHODS FOR TREATMENT OF MALIGNANT TUMOR USING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITY | 2016 |
|
RU2765154C2 |
| APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
| METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS, USING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK-INHIBITING ACTIVITY | 2016 |
|
RU2779287C2 |
